MARK2 antibody
Quick Overview for MARK2 antibody (ABIN646684)
Target
See all MARK2 AntibodiesReactivity
Host
Conjugate
Application
-
-
Specificity
- Peptide ELISA: Antibody detection limit dilution 1:16,000. Western Blot: Approx 70kDa band observed in Human Brain (Cerebellum) lysates (calculated MW of 77.6kDa according to NP_004945.3). Recommended concentration: 0.3-1µg/ml.
-
Cross-Reactivity
- Human, Mouse (Murine), Rat (Rattus), Cow (Bovine)
-
Characteristics
- Goat Anti-MARK2 / PAR-1
-
Immunogen
- Peptide with sequence C-QNGKDSTAPQR, from the internal region of the protein sequence according to NP_001034557.1, NP_001034558.1, NP_004945.3, NP_059672.2 PresentationSupplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
-
-
-
-
Comment
-
This antibody recognizes the reported isoforms (NP_001034557.1, NP_004945.3)
-
Restrictions
- For Research Use only
-
-
-
Storage
- -20 °C
-
-
- MARK2 (MAP/microtubule Affinity-Regulating Kinase 2 (MARK2))
-
Alternative Name
- MARK2 / PAR-1
-
Background
- Synonyms: MARK2, MAP/microtubule affinity-regulating kinase 2, EMK1, MGC99619, PAR-1, ELKL motif kinase, ELKL motif kinase 1, protein-serine/threonine kinase, serine/threonine kinase
-
Gene ID
- 2011
-
NCBI Accession
- NP_001034557
-
Pathways
- SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Target
-